Singapore: Japanese company Nippon Telegraph and Telephone Corporation (NTT) has developed a conductive fiber by coating...
Singapore: Daiichi Sankyo and ArQule announced that the first patient has been enrolled in the pivotal phase III METIV-...
Tokyo: Sumitomo Dainippon Pharma Co. Ltd., Center for iPS Cell Research and Application, Kyoto University (CiRA) and Hit...
Biotechnology Industry Organization (BIO) has made an announcement that the organization has joined a coalition of organ...
Tokyo: In collaboration with the Institute for Frontier Medical Sciences at Kyoto University, a team of CiRA researchers...
Singapore: Marking a major achievement in Indian biosimilar history, India's Biocon announced that close on the heels of...
Tokyo: The National Pharmaceutical Council (NPC) has inducted Takeda Pharmaceuticals USA Inc. (Takeda), a wholly-owned s...
Singapore: Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a...
The international operation of Chinese pharmaceutical company, HUYA Bioscience International (HUYA) has expanded its Sen...
Singapore: Japan's Kowa Company and Chugai Pharmaceutical have entered into license agreement for liver cancer drug pere...
Daiichi Sankyo Company Limited has signed a license agreement with UK-based Cell Therapy Ltd for an exclusive license in...
Singapore: RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus...
Israel's Pluristem Therapeutics Inc. has announced that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has cl...
Singapore: ERT, a US-based service provider to biopharmaceutical organizations, medical device companies and contract re...
Based on a notification received from the Japanese Ministry of Health, Labour and Welfare, Daiichi Sankyo Company Limite...
Singapore: Otsuka Pharmaceutical reached an agreement to establish a joint venture (JV) in the functional food and bever...
In the biomedical sector, the combination of latest technology and a strong business model is considered to be ideal. Th...
In a step to upgrade its pharmacovigilance services, Allergan Japan has announced that the company has implemented US-he...
